WallStSmart
AZTR

Azitra Inc

AMEX: AZTR · HEALTHCARE · BIOTECHNOLOGY

$0.22
-3.17% today

Updated 2026-06-05

Market cap
$3.62M
P/E ratio
P/S ratio
239.97x
EPS (TTM)
$-0.95
Dividend yield
52W range
$0 – $2
Volume
0.8M

Azitra Inc (AZTR) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item202020212022202320242025
Total assets$10.20M$7.17M$5.12M$7.36M$5.03M
Cash & equivalents$8.04M$3.49M$1.80M$4.55M$2.07M
Current assets$16.57M$8.49M$4.14M$2.54M$5.23M$3.02M
Total liabilities$35.97M$43.43M$2.20M$1.66M$1.22M
Current liabilities$1.00M$1.21M$2.22M$1.60M$1.38M$1.07M
Long-term debt$992019.00$6.60M
Shareholder equity$-25.77M$-36.26M$2.91M$5.70M$3.80M
Retained earnings$-17.69M$-26.63M$-37.31M$-48.60M$-57.57M$-68.52M
Accounts receivable$528350.00$334178.00$266208.00$223474.00$101896.00$141295.00
Inventory$216886.00$-215219.00
Goodwill$246.17M

Frequently asked questions

How much free cash flow does AZTR generate?

AZTR produced $-11.41M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is AZTR's balance sheet healthy?

AZTR holds $2.07M in cash and equivalents against — in long-term debt, on $3.80M of shareholder equity. That debt is best read against the cash flow the business throws off each year.